Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
Arrowhead Pharmaceuticals’ Lincense Collaboration Agreement with Sarepta Therapeutics
Apollo Therapeutics’ Exclusive License Agreement with Sunshine Lake Pharma
Ropes & Gray represented Apollo Therapeutics in the transaction. Apollo Therapeutics Group Limited (“Apollo”) and Sunshine Lake Pharma Co., Ltd. have entered into an exclusive license...
Kailera Therapeutics’ $400 Million Series A Financing
Ropes & Gray advised Kailera Therapeutics, Inc. on the transaction. Kailera Therapeutics, Inc. (“Kailera”) announced raising $400 million in Series A financing. Kailera announced its launch...
Gauge Capital’s Investment in AGT Robotics
Ropes & Gray and Blake, Cassels & Graydon represented Gauge Capital in the transaction. Gauge Capital (“Gauge”) announced its strategic growth investment in AGT Robotics, a...
Pharmacosmos Group’s Acquisition of G1 Therapeutics
Arnold & Porter Kaye Scholer advised Pharmacosmos, while Ropes & Gray and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented G1 Therapeutics on the deal....
Planet Fitness’ $280 Million Accelerated Share Repurchase
Ropes & Gray represented Planet Fitness, Inc. in the deal. Planet Fitness, Inc. (NYSE: PLNT) announced that it has entered into a $280 million accelerated share...
Nona Biosciences’ Global License and Option Agreement with AstraZeneca
Ropes & Gray advised Nona Biosciences on the deal. Nona Biosciences announced it has entered into a license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for preclinical monoclonal...
Gilgamesh Pharmaceuticals’ Collaboration with AbbVie
Ropes & Gray represented Gilgamesh Pharmaceuticals in a transaction. Gilgamesh Pharmaceuticals announced it has entered into a collaboration and option-to-license agreement with AbbVie (NYSE: ABBV) to...
Chiesi Group’s Collaboration with Gossamer Bio
Ropes & Gray advised Chiesi Group on the transaction, and Latham & Watkins advised Gossamer Bio. Chiesi Group announced it has entered into a global collaboration...
Loar Holdings’ $308 Million Initial Public Offering
Benesch, Friedlander, Coplan & Aronoff advised Loar Holdings on the offering, and Ropes & Gray advised the underwriters. Loar Holdings Inc. (NYSE: LOAR) announced the pricing...
Biohaven’s $264.5 Million Follow-On Offering
Maples and Calder acted as British Virgin Island counsel to Biohaven Ltd., and Sullivan & Cromwell acted as US counsel, while Ropes & Gray represented the...
BRP’s C$139 Million Shares Offering
Ropes & Gray and Stikeman Elliott represented Bain Capital and BRP in the offering, while Fasken Martineau DuMoulin represented the Selling Shareholder, and McCarthy Tétrault, Simpson...